IMVIQ
IMV Inc

3,573
52W High
$0.0195
Volume
3.00
52W Low
$0.00
Price
$0.00
50D MA
$0.00
IMVIQ Fundamentals
Beta
0.00
Avg. Volume
0.10
Loading...
Loading...

About

IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. The company was founded on May 18, 2007 and is headquartered in Dartmouth, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is the 52-week high for IMV Inc?

Latest IMVIQ News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.